Literature DB >> 16314539

When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk.

Philip Greenland, Patrick G O'Malley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16314539     DOI： 10.1001/archinte.165.21.2454

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  38 in total

Review 1.  Blood biologic markers of stroke: improved management, reduced cost?

Authors:  Alison E Baird
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

2.  The association between elevated levels of inflammation biomarkers and coronary artery disease and death.

Authors:  Gordon D O Lowe
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

3.  Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.

Authors:  Lei Yu; Robert S Wilson; Julie A Schneider; David A Bennett; Patricia A Boyle
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Novel markers of inflammation in atherosclerosis.

Authors:  Salim S Virani; Venkateshwar R Polsani; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

5.  A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data.

Authors:  Hajime Uno; Lu Tian; Tianxi Cai; Isaac S Kohane; L J Wei
Journal:  Stat Med       Date:  2012-10-05       Impact factor: 2.373

6.  Discordances among different tools used to estimate cardiovascular risk in postmenopausal women.

Authors:  Pascal Pelletier; Annie Lapointe; Nathalie Laflamme; Marie-Eve Piché; Stanley John Weisnagel; André Nadeau; Simone Lemieux; Jean Bergeron
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

7.  Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women.

Authors:  Mardge H Cohen; Anna L Hotton; Ronald C Hershow; Alexandra Levine; Peter Bacchetti; Elizabeth T Golub; Kathryn Anastos; Mary Young; Deborah Gustafson; Kathleen M Weber
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

8.  Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort.

Authors:  Thomas A Gaziano; Cynthia R Young; Garrett Fitzmaurice; Sidney Atwood; J Michael Gaziano
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

9.  Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community.

Authors:  Yariv Gerber; Shannon M Dunlay; Allan S Jaffe; Joseph P McConnell; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Atherosclerosis       Date:  2008-08-07       Impact factor: 5.162

10.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.